Lopinavir-Ritonavir Does Not Offer Substantial Benefit in Severe COVID-19 Medical Countermeasures March 18, 2020 …
LJI Scientists Identify Potential Targets for Immune Responses to SARS-CoV-2 Research March 15, 2020 …
Critical Bioeconomy Asset in Need of Attention: BSL-3 and BSL-4 Laboratories in the U.S. Medical Countermeasures March 6, 2020 …
Understanding Public Perceptions of Bioterrorism to Inform Risk Communication Research March 6, 2020 …
Passive Immunization with mAbs Against Aerosolized Ricin Toxin Medical Countermeasures March 6, 2020 …
The Case for a Seven-Gene-Deleted African Swine Fever Virus vs. Live Attenuated Vaccine Research March 5, 2020 …
Molecular and Serological Investigation of SARS-CoV-2: Implication of Multiple Shedding Routes Research February 28, 2020 …
U.S. Ebola Treatment Center Costs and Sustainability if Federal Funding Withdrawn Policy + Initiatives February 25, 2020 …
Trial Shows Two Drugs Not Better Than One When Treating MRSA Antimicrobial Resistance February 24, 2020 …
